Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Belldegrun

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Cancer|November 1, 1993
Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumorsJ E Janik, M Sznol, W J Urba, et al.
Cancer Research|November 3, 2001
Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factorC L Tso, A Zisman, A Pantuck, et al.
Urology|March 12, 1998
Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-GuérinM F Sarosdy, M J Manyak, A I Sagalowsky, et al.
Cancer Journal (Sudbury, Mass.)|October 19, 2000
Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cellsC L Tso, W H McBride, J Sun, et al.
Nature Medicine|April 1, 1997
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID miceK A Klein, R E Reiter, J Redula, et al.
British Journal of Cancer|November 8, 2006
Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosisY C Yang, M L Lu, J Y Rao, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Cancer|November 1, 1993
Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumorsJ E Janik, M Sznol, W J Urba, et al.
Cancer Research|November 3, 2001
Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factorC L Tso, A Zisman, A Pantuck, et al.
Urology|March 12, 1998
Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-GuérinM F Sarosdy, M J Manyak, A I Sagalowsky, et al.
Cancer Journal (Sudbury, Mass.)|October 19, 2000
Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cellsC L Tso, W H McBride, J Sun, et al.
Nature Medicine|April 1, 1997
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID miceK A Klein, R E Reiter, J Redula, et al.
British Journal of Cancer|November 8, 2006
Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosisY C Yang, M L Lu, J Y Rao, et al.
Pageof 13